A human-cell-based pancreas-liver microphysiological system serves as a preclinical platform for studying glucose–insulin homeostasis and disease mechanisms of glucose dysregulation, offering a tool for identifying targets and testing drugs.
- Sophie Rigal
- Belén Casas
- Liisa K. Vilén
